thehill.com

thehill.com
Share

thehill.com

 •  February 5

Several hundred "right to try" critics sent a letter to House Energy and Commerce leaders expressing their “strong opposition” to the bill President Trump urged Congress pass in his State of the Union speech last week. Supporters of the legislation believed Trump’s endorsement provided a jolt of momentum to the legislation, which would let patients...

thehill.com

 •  January 31

President Trump is calling on Congress to pass a bill aimed at allowing terminally ill patients to request access to experimental drugs the Food and Drug Administration (FDA) hasn’t yet approved. “We also believe that patients with terminal conditions, terminal illness, should have access to experimental treatment immediately that could potentially...

thehill.com

 •  January 25

Five years ago — in September 2012 — the Centers for Disease Control and Prevention (CDC) began investigating a widespread outbreak of fungal meningitis. Cases appeared in states from New Jersey to Idaho, from New Hampshire to Texas. But unlike the more common forms of meningitis (bacterial and viral), the unusual fungal version of the disease —...

thehill.com

 •  January 20

The Food and Drug Administration (FDA) is considering a new plan to promote reduced-risk tobacco products over cigarettes that administrators hope will lower rates of smoking in future generations. In a two-pronged plan, the FDA aims to significantly cut the amount of nicotine in cigarettes and review a number of cigarette alternatives with lower...

thehill.com

 •  January 18

Some American politicians—including, it seems, both Hillary Clinton and Donald Trump—want to reduce the high cost of prescription drugs by imposing government price controls. But there’s a problem: price controls kill. Forty centuries of human experience have shown that price controls do not work, and often harm the very people they’re intended to...

thehill.com

 •  January 8

Koch brothers-backed groups are launching a campaign urging Congress to pass legislation allowing terminally ill patients to request access to experimental drugs the Food and Drug Administration (FDA) hasn’t approved. Nearly 40 states have this law, known as “Right to Try,” already on their books. But Freedom Partners, in partnership with Americans...

thehill.com

 •  November 30, 2017

Occasionally we encounter a simple tweak in public policy that would be a win-win -— if it weren’t for politicians, bureaucrats and stakeholders zealously guarding their self-interest. An example is a reform that would both help combat shortages of critical drugs and put downward pressure on prices: reciprocity of drug approvals between FDA and...

thehill.com

 •  October 25, 2017

Patients are about to have more choices when it comes to the treatment of chronic disease. Biosimilars are a new class of drug that have the potential to increase access to lifesaving treatments and reduce costs. Recently, the U.S. Food and Drug Administration (FDA) accepted applications for two biosimilars that would help treat breast cancer, and...

thehill.com

 •  October 11, 2017

Doctors and hospitals are increasingly being paid not for the quantity of care they provide, but for the outcome or quality of care patients receive. The emerging trend in health care is about rewarding value, rather than volume. This is the future, where there is less focus on the number of tests or treatments a patient receives and more focus on...

thehill.com

 •  September 30, 2017

The Trump administration this week delayed the implementation of a rule under the Affordable Care Act meant to punish drug companies for price gouging, according to a new report. The Department of Health and Human Services (HHS) on Thursday quietly logged the delayed rollout of the rule into the federal register, Mic reports. The rule was initially...